Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertolini

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Haematologica|March 8, 2005
Stem cell plasticity: time for a reappraisal?Roberto M Lemoli, Francesco Bertolini, Ranieri Cancedda, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Hepatocyte-conditioned medium sustains endothelial differentiation of human hematopoietic-endothelial progenitorsVeronica Bordoni, Tonino Alonzi, Lucia Zanetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancerPier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Journal of Thrombosis and Haemostasis : JTH|August 8, 2020
Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe casesPatrizia Mancuso, Antonio Gidaro, Giuliana Gregato, et al.
Carcinogenesis|January 15, 2014
Paradoxic effects of metformin on endothelial cells and angiogenesisKatiuscia Dallaglio, Antonino Bruno, Anna R Cantelmo, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabineGiuseppe Curigliano, Vincenzo Bagnardi, Francesco Bertolini, et al.
Breast (Edinburgh, Scotland)|February 21, 2012
Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumabSilvia Dellapasqua, Vincenzo Bagnardi, Francesco Bertolini, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Haematologica|March 8, 2005
Stem cell plasticity: time for a reappraisal?Roberto M Lemoli, Francesco Bertolini, Ranieri Cancedda, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Hepatocyte-conditioned medium sustains endothelial differentiation of human hematopoietic-endothelial progenitorsVeronica Bordoni, Tonino Alonzi, Lucia Zanetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancerPier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Journal of Thrombosis and Haemostasis : JTH|August 8, 2020
Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe casesPatrizia Mancuso, Antonio Gidaro, Giuliana Gregato, et al.
Carcinogenesis|January 15, 2014
Paradoxic effects of metformin on endothelial cells and angiogenesisKatiuscia Dallaglio, Antonino Bruno, Anna R Cantelmo, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabineGiuseppe Curigliano, Vincenzo Bagnardi, Francesco Bertolini, et al.
Breast (Edinburgh, Scotland)|February 21, 2012
Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumabSilvia Dellapasqua, Vincenzo Bagnardi, Francesco Bertolini, et al.
Pageof 17